Publications by authors named "Maria E Amarillo"

Claim this Profile
C
Co-expression of PD1+ and HLA-DR+ in CD8+ T cells is increased in tonsils of children with EBV primary and persistent infection.
María Eugenia Amarillo, Karen Lindl, Veronica Lapido, Ignacio E Rojas Campión, M Soledad Collado

Front Immunol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pandemic-Driven Shifts in Epstein-Barr Virus (EBV) Epidemiology: Single Center Study.
Maria Eugenia Amarillo, Karen Lindl, Mercedes García Lombardi, Maria Victoria Preciado, Elena De Matteo

Viruses· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epstein Barr Virus (EBV) Latent Membrane Protein 1 (LMP-1) Regulates Functional Markers in Intermediate and Non-Classical Monocytes.
Agustina Moyano, Ana Colado, María Eugenia Amarillo, Elena De Matteo, María Victoria Preciado

Cancers (Basel)· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hydrocortisone cardioprotection in ischaemia/reperfusion injury involves antioxidant mechanisms.
Daiana S Escudero, Juliana C Fantinelli, Valeria R Martínez, Luisa F González Arbeláez, María E Amarillo

Eur J Clin Invest· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tonsillar cytotoxic CD4 T cells are involved in the control of EBV primary infection in children.
María Eugenia Amarillo, Agustina Moyano, Natalia Ferressini Gerpe, Elena De Matteo, Maria Victoria Preciado

Sci Rep· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EBV Impact in Peripheral Macrophages' Polarization Cytokines in Pediatric Patients.
Agustina Moyano, Natalia Ferressini Gerpe, Maria Eugenia Amarillo, Elena De Matteo, Maria Victoria Preciado

Viruses· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PDE5 inhibition improves cardiac morphology and function in SHR by reducing NHE1 activity: Repurposing Sildenafil for the treatment of hypertensive cardiac hypertrophy.
Daiana S Escudero, María S Brea, Claudia I Caldiz, María E Amarillo, Jorge O Aranda

Eur J Pharmacol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis